Vericel (VCEL) Inventory Average (2014 - 2026)
Vericel's (VCEL) quarterly Inventory Average came in at $18.0 million in Q1 2026, up 4.15% year-on-year from $17.2 million in Q1 2025, and up 0.55% quarter-over-quarter from $17.9 million in Q4 2025.
Vericel (VCEL) Inventory Average (2014 - 2026) Analysis & Trends
Vericel has disclosed Inventory Average across 13 years of filings, most recently posting $18.0 million for Q1 2026.
- Inventory Average for Q1 2026 came in at $18.0 million, up 4.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.0 million (up 4.15% YoY), and the FY2025 annual result was $17.5 million, up 14.68% from the prior year.
- Inventory Average came in at $18.0 million for Q1 2026 at Vericel, up from $17.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $18.0 million in Q1 2026 to a low of $12.9 million in Q4 2023.
- The 5-year median for Inventory Average is $15.7 million (2023), against an average of $15.6 million.
- Across the five-year window, Inventory Average soared 41.1% in 2022 and slipped 21.42% in 2023, its largest moves.
- Vericel's Inventory Average stood at $16.4 million in 2022, then fell by 21.42% to $12.9 million in 2023, then rose by 28.87% to $16.6 million in 2024, then gained by 7.81% to $17.9 million in 2025, then advanced by 0.55% to $18.0 million in 2026.
- The last three Inventory Average figures came in at $18.0 million (Q1 2026), $17.9 million (Q4 2025), and $17.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 17.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.96 Mn |
| Dec 31, 2025 | 17.86 Mn |
| Sep 30, 2025 | 17.49 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Mar 31, 2025 | 17.24 Mn |
| Dec 31, 2024 | 16.56 Mn |
| Sep 30, 2024 | 15.32 Mn |
| Jun 30, 2024 | 14.22 Mn |
| Mar 31, 2024 | 13.32 Mn |
| Dec 31, 2023 | 12.85 Mn |
| Sep 30, 2023 | 13.25 Mn |
| Jun 30, 2023 | 14.63 Mn |
| Mar 31, 2023 | 15.68 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 16.33 Mn |
| Jun 30, 2022 | 15.16 Mn |
| Mar 31, 2022 | 13.88 Mn |
| Dec 31, 2021 | 13.22 Mn |
| Sep 30, 2021 | 13.01 Mn |
| Jun 30, 2021 | 11.64 Mn |